phase readout
saveNCT07579884: To Evaluate the Safety and Efficacy of RP902 Tablets
NOT_YET_RECRUITINGupdated 1d ago
community read0 votes
Sponsor: Risen (Suzhou) Pharma Tech Co., Ltd.. Phase: PHASE2. Conditions: Mild Cognitive Impairment (MCI)
view source ↗
comments(0)
5-min edit window · permanent after that